in influencing the business of companies in monetary terms, this dimension was neglected by almost all the contributions. In order to fill such a gap, we adopt an accounting perspective for analysing the open behaviours of firms, by investigating the operational and financial open transactions in both inbound and outbound processes. The research question we aim at answering is: how do companies implement OI within their business models, in order to incorporate external technologies and exploit internal innovative outputs on external markets. In order to define the OI business models of companies we analysed OI transactions through accounting data of 271 world top R&D spending companies in biopharmaceutical and technology hardware & equipment industries for the three years period 2010-2012, for a total of 813 consolidated annual reports analysed. Both the framework applicability and its explicative power and usefulness were validated. In what follows, after reviewing literature contributions on OI adoption models, methodology is presented and applied to the selected sample, results are discussed and conclusions will close the work.
Literature Review
The theme of how companies are implementing OI is largely investigated in literature and a number of different OI business models are described.
The most acknowledged taxonomy distinguishes inbound from outbound OI (Gassmann and Enkel, 2004 ) -the former addressed to enrich the knowledge base of companies through relationships with external sources of knowledge, the latter to bring internal ideas to external marketsand different scholars adopted the inbound vs. outbound approach to define OI business models. Podmetina et al. (2011) classified companies in nine clusters, from "no buy, no sell", i.e. a total closed behaviour, to "active buy, active sell" when both inbound and outbound activities are relevant. Gianiodis et al. (2010) defined four models for open firms: "innovation seekers" who buy technology from outside, "innovation providers" selling their own technology, "intermediaries" between the first two categories and "open innovators" being capable to act as both innovation seekers to fill technology gaps and innovation providers to divest a particular technological trajectory. Dahlander and Gann (2010) add to the inbound vs. outbound dimension the pecuniary vs. nonpecuniary nature of OI activities, defining two forms of inbound innovationacquiring and sourcing -and two types of outbound innovation -selling and revealing.
Several contributions focus on the practices that companies adopt for pursuing OI (Bianchi et Tranekjer and Knundsen (2012) add to the analysis of inbound and outbound practices also the internal mechanisms fostering OI, such as supporting employees working on own ideas and entrepreneurial activities within the company. Also Cheng and Huizingh (2014) add one dimension, by investigating coupled practices combining importing and exporting mechanisms. Yet, a large part of contributions in literature focus only on inbound processes, neglecting the role of outbound OI.
After the definition of Laursen and Salter (2006) , different studies outlined open models by analysing OI breadth and depth, the former being the number of external sources of knowledge, the latter the degree of use of such sources. Keupp and Gassmann (2009) identified three clusters of open companies: "professionals" collaborating both broadly and deeply, "explorers" with a medium to large breadth and a medium degree of depth, "scouts" with a medium to large breadth and a low degree of depth. Idrissia et al. (2012) define "open" the companies with high breadth and depth, "user" the companies with high breadth and low depth, "interactive" the ______________________________________________________________________________________________________________ 
______________

Methodological Framework
From the analysis of companies' annual reports, four kinds of transactions can be found in the OI market related to inbound vs. outbound processes having an operational vs. financial nature: costs and revenues are respectively inbound and outbound operational transactions disclosed in the income statement of companies, while additions and disposals are the new investments and divestments in intangibles, disclosed in the balance sheet, which respectively represent inbound and outbound financial transactions. A comprehensive description of our measurement framework for OI can be found in Michelino et al. (2014) , where the openness of a company is summarized by comparing open costs, revenues, intangible investments (additions) and divestments (disposals) to its total costs, revenues and intangibles:
In this paper we are focusing on the different strategies for pursuing OI and we can distinguish five broad categories of open transactions: As to operational transactions, three different underlying logics can be defined, from an increase of knowledge for both the parties, through the delivery of a black box, to the concession of a right without the transfer of ownership. As regards financial transactions, two different logics can be defined as well. When a separate acquisition occurs, a focalized interest on an intangible, e.g. a specific patent, can be outlined. On the contrary, within business combinations, mergers and acquisitions (BCMAs), the acquiring company can be interested not only on the recognized intangibles, but also in the skills of human resources working in the acquired firm. Such a distinction makes it important to consider the goodwill arising from BCMAs as a proxy for intellectual capital, consistently with literature (Boekestein, 2009; Brännström et al., 2009 ). Thus, five business models for OI can be defined: collaboration, outsourcing, licensing, trading and incorporation ( Table 1 ). The first four have both, inbound and outbound components, while the fifth can be defined only inbound since, when an incorporation occurs, the incorporated company does not exist anymore and no annual report is written off for it. The intensity-time analysis leads to the definition of four categories of business models for each company:
• if a component is both intense and continuous over time, we can define it characteristic since it strongly characterizes the business of the company all over a long period of time; • if it is continuous over time but not intense, it can be defined ancillary since the company constantly performs the activity, even if it is not very relevant if compared to its total business; • if it is intense but not continuous over time, we can define it exceptional since it strongly but discontinuously characterizes the business of the company; • finally, if it is neither intense nor continuous over time it can be defined negligible.
A third variable can be used to define the pervasiveness of a business model within a given set of companies, e.g. an industry or a segment: frequency. If we have a sample of N companies with n ≤ N of them having a specific item, we can define its frequency as:
Thus, given a set of companies, we can define the mean values of intensity and time and compare them to the frequency, so that for each of the four aforementioned categories we can separate the common behaviours from the uncommon ones. For example, if the mean values of intensity and time are high and frequency is high, the model is characteristic for the whole sample, whereas, if the frequency is low it is characteristic only for a niche of companies.
By multiplying the three variables, a synthetic measure of the relevance of each model can be defined; in particular, if we are analysing open business models over a period of Y years, a percentage indicator can be calculated as: Table 2 , while in Tables 3 and 4 the mean values of intensity, time and frequency for each segment are reported (mean values for intensity and time were calculated only for those companies with a non-zero value). In Figures 1 to 5 a positioning map is reported for each segment: x and y axes respectively represent time and intensity, while the frequency is defined by the dimension of the bubble. The biotechnology segment is characterized by the highest values of openness. Collaboration revenues and outsourcing costs are characteristic activities since they are both intense and continuous over time. Further, licensing and outsourcing revenues as well as collaboration and licensing costs can be considered ancillary given their lower intensity but still high continuity over time. Actually, in this segment OI strongly characterizes the income statement of the companies. As a matter of fact, biotech companies, being still in the development phase, do not sell products, but rather enter into agreements with other biopharmaceutical companies for joint R&D projects and earn from licensing their intellectual property. Thus, most part of the EBIT of companies derives from OI transactions. In particular, OI revenues are widespread in more than half of the companies of the segment, while OI costs can be detected in about one third of the sample.
On the contrary, trading and incorporation strategies are less continuous over time. In particular, incorporation is exceptional since, even if spin-ins are seldom performed by biotech companies, their influence on the total business is very high, while trading is negligible since the separate acquisition or disposal of intangibles does not increase or decrease the total value of intangibles in a significant way. Additions are more widespread than disposals all over the segment, with 45% to 53% companies performing the former and 29% the latter. Just like biotech firms, the most intense and continuous activity for pharmaceutical companies is outbound collaboration, which is also quite frequent in the segment (50%), but the most frequent strategy in the sample, even if with a low intensity, is trading, with 65% companies selling and 81% acquiring intangibles. In particular, companies in the pharmaceutical segment show a dynamic management of their brand portfolio, by acquiring and selling trademarks. Two characteristic models can be detected for a niche of companies licensing for semiconductors firms and inbound outsourcing for telecommunications equipment ones. T former is a characteristic of owning a dominant design in semiconductors technologies it to other firms; the latter can be explain through IT modularity, with outsourcing the development of one or more modules to third parties. The results obtained since now can be summarized by the definition of the relevance of each component for each segment (Table 5 ):
Open innovation strategies for semiconductors companies
• the most relevant strategy for biotech companies is outbound collaboration, followed by outbound licensing and inbound outsourcing; Such findings were also confirmed through regression analyses performed using the intensity values of the different components as explicating variables for openness: using a stepwise method we can define the components which better explain open each segment by analysing their entry order. 
Open innovation strategies for telecommunications equipment companies
The results obtained since now can be summarized by the definition of the nent for each most relevant strategy for biotech companies is outbound collaboration, followed by outbound licensing and inbound
• in the pharmaceutical segment, outbound collaboration is followed by incorporation; • in all the segments of the technology hardware industry, incorporation is the primary and most relevant strategy. Such findings were also confirmed through regression analyses performed using the different components as explicating variables for openness: using a stepwise method we can define the components which better explain openness for ing their entry order.
In particular, we considered models where the adjusted R value equal or greater than considered the regression usted R-square reached a value equal or greater than 0.8 (Table 6) (Hagedoorn and Roijakkers, 2002; Powell et al., 2005) . As a matter of fact, large and long established pharmaceutical companies behave as innovation seekers acquiring R&D services from small and young biotech firms (Powell et al., 1996) . Conversely, as to technology hardware & equipment industry, OI transactions are mainly financial and represented by goodwill; thus, in this industry BCMAs occur to acquire know-how and, therefore, goodwill can be effectively considered as a proxy of intellectual capital. This is consistent with literature, which reports know-how, technologies and capabilities as the valuable resources driving the recourse to BCMAs ( incorporation strategy is a better solution for technology hardware & equipment firms because of the modularity of IT design: many computer and chip designs are based on compatible independent components, and this makes it simpler to acquire readily integrated technology (Bower, 2001 ).
Conclusion
The paper examines the business models adopted by companies in order to embrace the OI paradigm: collaboration, outsourcing, licensing, trading and incorporation. The work is based on the analysis of consolidated annual reports of 271 R&D intense companies operating in bio-pharmaceutical and technology hardware & equipment industries: open costs and revenues, new investments and divestments of intangibles are analysed for the three years period 2010-2012. In the bio-pharmaceutical industry outbound strategies based on open revenues are very frequent, with higher intensity in the biotechnology segment than in the pharmaceutical one; within technology hardware & equipment companies, the most characterizing strategy is the inbound incorporation of other firms. Through this analysis, both the framework applicability and its explicative power and usefulness were validated.
The paper addresses the need for operative, practical instruments, which can help managers to monitor and control their innovation strategies after an openoriented approach. Given the availability and objectivity of annual report figures, defining OI models through the analysis of financial statements can help decisionmakers to assess the status of their own open strategies and compare it over time and space, also allowing the benchmarking with competitors.
